Content

Title Post Datesort ascending Type Category
Vitamin D to Prevent Respiratory Tract Infections: Is the Evidence Dazzling or Disappointing? 06/26/2017

Commentary Infectious Diseases, Other
For patients with DM who do NOT use insulin, self-monitoring of blood glucose should: 06/19/2017

Poll
It’s All Relative: Rivaroxaban for Extended Secondary Prevention of VTE 06/10/2017

Commentary Anticoagulation, VTE
Fish Oil (n-3 fatty acids) supplementation during pregnancy to prevent asthma: 05/12/2017

Poll
For high-risk patients (e.g. CAD+DM) who require antiplatelet (mono)therapy, I recommend: 04/14/2017

Poll
Peeling Back the Layers on Coated Aspirin 04/14/2017

Commentary CAD, Diabetes, Stroke
Antithrombotic Therapy Following Stent Placement in Patients with A-Fib: Should DOACs Be Preferred? 03/24/2017

Commentary Anticoagulation, CAD, Stroke
Getting Some SHUTi: Using the Internet to Treat Patients with Insomnia 03/13/2017

Commentary Other, Patient Mgmt
For African American patients with hypertension and diabetes but no comorbidities, the best initial treatment choice is: 02/25/2017

Poll
Think Before You Make a RAS Decision: Evaluating the Use of RAS Blockers in Patients with Diabetes 02/24/2017

Commentary Diabetes, Hypertension
Helpful, Harmful, or Futile — Antidepressant Use in Patients with Heart Failure 02/09/2017

Commentary Heart Failure, Other
Ten Pitfalls to Avoid When Evaluating the Primary Literature 01/25/2017

Commentary Other, Patient Mgmt
Helping patients get health screenings and prepare for the tests is... 01/13/2017

Poll
Is There a Role for Fixed-Ratio Injectable Combinations in Type 2 Diabetes? 01/13/2017

Commentary Diabetes
Bowel Cleansing Regimens – Pick Your Poison (Wisely)! 12/29/2016

Commentary Other, Patient Mgmt
Preventing Pediatric Dosing Errors – Is It Time to Dump the Medicine Cup? 12/06/2016

Commentary Patient Mgmt
Now that empagliflozin is FDA-approved to reduce the risk of CV events in patients with DM 2 and CVD ... 12/06/2016

Poll
Sweetening the Deal: Effects of SGLT-2 Inhibitors on Kidney Disease Progression 11/11/2016

Commentary Diabetes, Kidney Disease
Coprescribing Naloxone: A Moral Imperative? 11/07/2016

Commentary BMJ Disease, Pain, Patient Mgmt
The pharmacists patient care process has been ... 10/24/2016

Poll
Liraglutide - Second Line Option in the Treatment of DM-2 or NOT. 10/05/2016

Forum
Eleven Things Every Clinician Should Know About the “Egregious Eleven” 09/29/2016

Commentary Diabetes
Co-prescribing naloxone to patients who take opioids for chronic pain ... 09/15/2016

Poll
HIP-HIP-HOPE-3! Expanded role for statin therapy for primary prevention 09/15/2016

Commentary CAD, Lipids
Liraglutide: The New LEADER for Second Line Therapy in Diabetes Management? 09/02/2016

Commentary Diabetes

Pages